Brief: CARsgen Therapeutics Says Net Loss Was Around RMB798 Mln For Year
18/03/2025 15:01
March 18 (Reuters) - CARsgen Therapeutics Holdings Ltd 2171.HK: NET LOSS WAS AROUND RMB798 MILLION FOR YEAR GROUP'S REVENUE WAS AROUND RMB39.4 MILLION FOR YEAR Further company coverage: 2171.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer